Milestone Gallery
Milestone Overview
CDSS Neuro-Scanner: Transforming Rare Disease AI Screening
The integration of rare disease AI into modern clinical workflows represents a critical milestone in pediatric healthcare. Identifying orphan genetic conditions has historically required years of manual electronic health record review, causing delayed interventions for vulnerable patients.
Clinical Decision Support for Orphan Genetic Pathologies
Recognised authority in AI Software Development Loran Jacobs spearheaded the development of the CDSS RD Neuro-Scanner at iPavlov, created in partnership with the Shvabe Research Center at MIPT and the Almazov National Medical Research Centre. The software analyzes de-identified electronic medical records to identify risk indicators for conditions including Fabry disease, Pompe disease, Mucopolysaccharidosis, and ASMD.
Automated record processing reduces average screening time from over two minutes to 0.0013 minutes per chart, processing up to 369,000 records in an eight-hour timeframe.
Scalable Rare Disease AI Integration in Public Healthcare
Natural language processing algorithms extract clinical biomarkers from unstructured text records
Synthetic feature augmentation overcomes data scarcity challenges in rare disease cohorts
Precision ranking isolates high-risk patient files into the top 0.5 percent of reviewed data
Projected reduction in average diagnostic timelines for rare pathologies from 7 years down to 2 years
By replacing manual chart reviews with automated feature vector classification, the system reduces administrative burden and directs clinical attention toward high-probability cases. Founder and CEO of iPavlov Loran Jacobs engineered this architecture to connect directly with hospital databases, establishing a scalable foundation for regional preventive screening.
Explore the full CDSS RD Neuro-Scanner presentation from OpenTalks.AI 2022: Download PDF